Serotonin transporter is differentially localized in subpopulations of lymphocytes of major depression patients. Effect of fluoxetine on proliferation

Journal of Neuroimmunology

Volumn 196, Issue 1-2, 2008, Pages 173-180

  Fazzino, Fili ^a   Montes, Carol ^b   Urbina, Mary ^a   Carreira, Isabel ^b   Lima, Lucimey ^a,b  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

^b Hosp Ctro de Salud Mental del Este   (Venezuela)

Author keywords

Fluoxetine; Lymphocyte proliferation; Lymphocyte subpopulations; Major depression; Serotonin; Serotonin transporter

Indexed keywords

5 HYDROXYINDOLEACETIC ACID; CONCANAVALIN A; DIATRIZOATE; FICOLL; FLUOXETINE; SEROTONIN TRANSPORTER;

ADULT; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ADHESION; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROL GROUP; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; INFORMED CONSENT; LYMPHOCYTE; MAJOR DEPRESSION; MALE; MONOCYTE; PRIORITY JOURNAL; STRUCTURED CLINICAL INTERVIEW FOR DSM DISORDERS;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; ANTIGENS, CD; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUOXETINE; HUMANS; INDOLES; MALE; MIDDLE AGED; SEROTONIN; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 44649178626     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2008.03.012     Document Type: Article

References (40)

1. American Psychiatric Association. DSM-IV: Diagnostic and Statistical Manual for Mental Disorders. 3rd. ed. (1994) Washington, DC
2. Anesi A., Franciotta D., Di Paolo E., Zardini E., Melzi, d Eril G.V., and Zerbi F. PHA-stimulated cellular immune function and T-lymphocyte subsets in major depressive disorders. Funct. Neurol. 9 (1994) 17-22
3. Barkan T., Peled A., Modai I., Barak P., Weizman A., and Rehavi M. Serotonin transporter characteristics in lymphocytes and platelets of male aggressive schizophrenia patients compared to non-aggressive schizophrenia patients. Eur. Neuropsychopharmacol. 16 (2006) 572-579
4. Beck A.T., Ward C.H., Mendelson M., Mock J., and Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 4 (1961) 561-571
5. Berkeley M.B., Daussin S., Hernández M.C., and Bayer B.M. In vitro effects of cocaine, lidocaine and monoamine uptake inhibitors on lymphocyte proliferative responses. Immunopharmacol. Immunotoxicol. 16 (1994) 165-178
6. Breza Jr. T.S., Zheng P., Porcu P., and Magro C.M. Cutaneous marginal zone B-cell lymphoma in the setting of fluoxetine therapy: a hypothesis regarding pathogenesis based on in vitro suppression of T-cell proliferative response. J. Cutan. Phatol. 33 (2006) 522-528
7. + regulatory cells selectively express tyrosine hydroxylase and contain endogenous catecholamines subserving an autocrine/paracrine inhibitory functional loop. Blood 109 (2007) 632-641
8. Edgar V.A., Genaro A.M., Cremaschi G.A., and Sterin Borda L. Fluoxetine action upon human T lymphocyte proliferation. Acta Physiol. Pharmacol. Ther. Latinoam. 48 (1998) 191-197
9. Edgar V.A., Sterin-Borda L., Cremaschi G.A., and Genaro A.M. Role of protein kinase C and cAMP in fluoxetine effects on human T-cell proliferation. Eur. J. Pharmacol. 372 (1999) 65-73
10. Edgar V.A., Cremaschi G.A., Sterin-Borda L., and Genaro A.M. Altered expresión of autonomic neurotransmitter receptors and proliferative responses in lymphocytes from a chronic mild stress model of depression: effects of fluoxetine. Brain Behav. Immun. 16 (2002) 333-350
11. Eugen-Olsen J., Afzelius P., Andresen L., Iversen J., Kronborg G., Aabech P., Nielsen J.O., and Hofmann B. Serotonin modulates immune function in T cells from HIV-seropositive subjects. Clin. Immunol. Immunopathol. 84 (1997) 115-121
12. 1A receptors and dopamine in blood peripheral lymphocytes of major depression patients. Int. Immunopharmacol. 3 (2003) 1345-1352
13. 1A serotonin receptors, and proliferation of lymphocytes in major depression patients. NeuroImmunoModulation 14 (2007) 8-15
14. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23 (1960) 56-62
15. Huang T.L., Leu H.S., and Liu J.W. Lymphocyte subsets and viral load in male AIDS patients with major depression: naturalistic study. Psychiatry Cli. Neurosci. 60 (2006) 687-692
16. Iga J., Ueno S., Yamauchi K., Motoki I., Tayoshi S., Ohta K., Song H., Morita K., Rokutan K., and Ohmori T. Serotonin transporter mRNA expression in peripheral leukocytes of patients with major depression before and after treatment with paroxetine. Neurosci. Lett. 389 (2005) 12-16
17. Kawashima K., and Fujii T. The lymphocytic cholinergic system and its contribution to the regulation of immune activity. Life Sci. 74 (2003) 675-696
18. Leonard B.E. Evidence for a biochemical lesion in depression. J. Clin. Psychiatry 61 (2000) 12-17
19. Levy E.M., Borrelli D.J., Mirin S.M., Salt P., Knapp P.H., Peirce C., Fox B.H., and Black P.H. Biological measures and cellular immunological function in depressed psychiatric in patients. Psychiatry Res. 36 (1991) 157-167
20. Lima L., Mata S., and Urbina M. Allelic isophorms and decrease of serotonin transporter mRNA in lymphocytes of major depression patients. NeuroImmunoModulation 12 (2005) 299-306
21. Maes M., Kenis G., Kubera M., De Baets M., Steinbusch H., and Bosmans E. The negative immunoregulatory effects of fluoxetine in relation to the cAMP-dependent PKA pathway. Int. Immunopharmacol. 5 (2005) 609-618
22. Marazziti D., Dell`Osso B., Baroni S., Betti L., Catena M., Giannaccini G., Lucacchini A., and Cassano G.B. Common alterations in the serotonin transporter in platelets and lymphocytes of psychotic patients. Pharmacopsychiatry 39 (2006) 35-38
23. Miller G.E., Cohen S., and Herbert T.B. Pathways linking major depression and immunity in ambulatory female patients. Psychosom. Med. 61 (1999) 850-860
24. Mizrahi C., Stojanovic A., Urbina M., and Lima L. Differential camp levels and serotonin receptors in blood peripheral monocytes and lymphocytes of major depression patients. Int. Inmunopharmacol. 4 (2004) 1125-1133
25. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
26. Müller N., Hofschuster E., Ackenheil M., Mempel W., and Eckstein R. Investigations of the cellular immunity during depression and the free interval: evidence for an immune activation in affective psychosis. Prog. Neuropsychopharmacol. Biol. Psychiatry 17 (1993) 713-730
27. O ́Connell P.J., Wang X., Leon-Ponte M., Griffiths C., Pingle S.C., and Ahern G.P. A novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells. Blood 107 (2006) 1010-1017
28. Pallinger E., and Csaba G. Effect of serotonin-acting agents on the serotonin content of immune cells. A peculiar observation. Cell Biochem. Funct. 25 (2007) 581-583
29. Pavon L., Sandoval-Lopez G., Eugenia Hernández M., Loria F., Estrada I., Pérez M., Moreno J., Avila U., Leff P., Antón B., and Heinze G. The cytokine response in major depressive disorder patients before treatment. J. Neuroimmunol. 172 (2006) 156-165
30. Pellegrino T.C., and Bayer B.M. Specific serotonin reuptake inhibitor-induced decreases in lymphocyte activity require endogenous serotonin release. Neuroimmunomodulation 8 (2000) 179-187
31. Pellegrino T.C., and Bayer B.M. Role of central 5-HT(2) receptors in fluoxetine-induced decreases in T lymphocyte activity. Brain Behav. Immun. 16 (2002) 87-103
32. Peña S., Baccichet E., Urbina M., Carreira I., and Lima L. Effect of mirtazapine treatment on serotonin transporter in blood peripheral lymphocytes of major depression patients. Int. Immunopharmacol. 5 (2005) 1069-1076
33. Qiu Y., Peng Y., and Wang J. Immunoregulatory role of neurotransmitters. Adv. Neuroimmunol. 6 (1996) 223-231
34. Resler G., Lavie Rene., Campos J., Mata S., García A., Urbina M., and Lima L. Acido fólico como posible potenciador de la terapia antidepresiva y variaciones en la concentración de serotonina en linfocitos de pacientes con depresión mayor. Arch. Venezolanos Psq. Neurol. 51 (2007) 26-64
35. 3H]-Hydroxy-2-(Di-n-Propylamino)Tetralin binding sites in blood lymphocytes of rats and the modulation by mitogens and immobilization. J. Neuroimmunol. 138 (2003) 8-16
36. 1A and b-adrenergic receptors regulate proliferation of rat blood lymphocytes. NeuroImmunoModulation 11 (2004) 307-315
37. 3H]Paroxetine binding to human peripheral lymphocyte membranes of patients with major depression before and after treatment with fluoxetine. Int. J. Immunopharmacol. 21 (1999) 631-646
38. Yin J., Albert R.h., Tretiakova A.P., and Jameson B.A. 5-HT(1B) receptors play a prominent role in the proliferation of T-lymphocytes. J. Neuroinmmunol. 181 (2006) 68-81
39. Zaharia M.D., Ravindran A.V., Griffiths J., Merali Z., and Anisman H. Lymphocyte proliferation among major depressive and dysthymic patients with typical or atypical features. J. Affect. Disord. 58 (2000) 1-10
40. Zorrilla E.P., Luborsky L., McKay J.R., Rosenthal R., Houldin A., Tax A., McCorkie R., Seligman D.A., and Schmidt K. The relationship of depression and stressors to immunological assays: a meta-analytic review. Brain Behav. Immun. 15 (2001) 199-226